Haemorrhage control in severely injured patients

The Lancet

Volumn 380, Issue 9847, 2012, Pages 1099-1108

  Gruen, Russell L ^a   Brohi, Karim ^b   Schreiber, Martin ^c   Balogh, Zsolt J ^d   Pitt, Veronica ^a   Narayan, Mayur ^e   Maier, Ronald V ^f  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTA; BLOOD CLOTTING FACTOR 7A; FIBRIN GLUE; FIBRINOGEN CONCENTRATE; FIBRINOGEN PLUS THROMBIN; FLOSEAL; HELISTAT; MICROCRYSTALLINE COLLAGEN; PROCOAGULANT; PROTHROMBIN COMPLEX; RECOMBINANT THROMBIN; UNCLASSIFIED DRUG; VITAGEL;

ACIDEMIA; ADAPTIVE IMMUNITY; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON OCCLUSION; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; COMPRESSION; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; FREEZE DRYING; GENE EXPRESSION; GENETIC VARIABILITY; HEMORRHAGIC SHOCK; HOMEOSTASIS; HUMAN; HYPOTENSION; HYPOTHERMIA; INFLAMMATION; INJURY; INNATE IMMUNITY; MICROCIRCULATION; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REPERFUSION INJURY; RESUSCITATION; TISSUE PERFUSION; WOUND DRESSING;

EID: 84866490453     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61224-0     Document Type: Review

References (94)

1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60: S3-11.
2. Schreiber MA. The beginning of the end for damage control surgery. Br J Surg 2012; 99: 10-11.
3. Szopinski J, Kusza K, Semionow M. Microcirculatory responses to hypovolemic shock. J Trauma 2011; 71: 1779-88.
4. Duchesne JC, McSwain NE, Cotton BA, et al. Damage control resuscitation: the new face of damage control. J Trauma 2010; 69: 976-90.
5. Zuidema MY, Zhang C. Ischemia/reperfusion injury: the role of immune cells. World J Cardiol 2010; 2: 325-32.
6. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012; 72: 1491-501.
7. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011; 208: 2581-90.
8. Desai KH, Tan CS, Leek JT, Maier RV, Tompkins RG, Storey JD. Dissecting inflammatory complications in critically injured patients by within-patient gene expression changes: a longitudinal clinical genomics study. PLoS Med 2011; 8: e1001093.
9. Beekley AC, Sebesta JA, Blackbourne LH, et al. Prehospital tourniquet use in Operation Iraqi Freedom: effect on hemorrhage control and outcomes. J Trauma 2008; 64: S28-37.
10. Kragh JF, Walters TJ, Baer DG, et al. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma 2008; 64: S38-49.
11. Kragh JF, Murphy C, Dubick MA, Baer DG, Johnson J, Blackbourne LH. New tourniquet device concepts for battlefield hemorrhage control. US Army Med Dept J 2011: 38-48.
12. Krieg JC, Mohr M, Ellis TJ, Simpson TS. Emergent stabilization of pelvic ring injuries by controlled circumferential compression: a clinical trial. J Trauma 2005; 59: 659-64.
13. Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251: 217-28.
14. Granville-Chapman J, Jacobs N, Midwinter MJ. Pre-hospital haemostatic dressings: a systematic review. Injury 2011; 42: 447-59.
15. Carless PA, Henry DA, Anthony DM. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 2003; 1: CD004171.
16. Frevert S, Dahl B, Lonn L. Update on the roles of angiography and embolisation in pelvic fracture. Injury 2008; 39: 1290-94.
17. Fu CY, Wang YC, Wu SC, et al. Angioembolization provides benefits in patients with concomitant unstable pelvic fracture and unstable hemodynamics. Am J Emerg Med 2012; 30: 207-13.
18. Burlew CC, Moore EE, Smith WR, et al. Preperitoneal pelvic packing/external fixation with secondary angioembolization: optimal care for life-threatening hemorrhage from unstable pelvic fractures. J Am Coll Surg 2011; 212: 627-28.
19. Letoublon C, Morra I, Chen Y, Monnin V, Voirin D, Arvieux C. Hepatic arterial embolization in the management of blunt hepatic trauma: indications and complications. J Trauma Injury Infect Crit Care 2011; 70: 1032-37.
20. Requarth JA, D'Agostino RB Jr, Miller PR. Nonoperative management of adult blunt splenic injury with and without splenic artery embolotherapy: a meta-analysis. J Trauma Injury Infect Crit Care 2011; 71: 898-903.
21. Ball CG, Kirkpatrick AW, D'Amours SK. The RAPTOR: Resuscitation with angiography, percutaneous techniques and operative repair. Transforming the discipline of trauma surgery. Can J Surg 2011; 54: E3-4.
22. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma Injury Infect Crit Care 2003; 54: 1127-30.
23. Frith D, Goslings JC, Gaarder C, et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8: 1919-25.
24. Mitra B, Cameron PA, Mori A, Fitzgerald M. Acute coagulopathy and early deaths post major trauma. Injury 2012; 43: 23-25.
25. Casstevens EC, MacLeod JB, Shaz B. Early trauma induced coagulopathy (ETIC) is associated with an increase in complications post-injury. Transfusion 2010; 50: 36A-37A.
26. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma Injury Infect Crit Care 2008; 65: 748-54.
27. Wafaisade A, Wutzler S, Lefering R, et al. Drivers of acute coagulopathy after severe trauma: a multivariate analysis of 1987 patients. Emerg Med J 2010; 27: 934-39.
28. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma Injury Infect Crit Care 2008; 64: 1211-17.
29. Cohen MJ, Call M, Nelson M, et al. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surgy 2012; 255: 379-85.
30. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245: 812-18
31. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43: 26-32.
32. Armand R, Hess Jr. Treating coagulopathy in trauma patients. Transfus Med Rev 2003; 17: 223-31.
33. Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma Injury Infect Crit Care 2011; 71: S427-34.
34. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-51.
35. Martini WZ. Fibrinogen availability and coagulation function after hemorrhage and resuscitation in pigs. Mol Med 2011; 17: 757-61.
36. Husmann B, Lefering R, Taeger G, Waydhas C, Ruchholtz S, Lendemans S. Influence of prehospital fluid resuscitation on patients with multiple injuries in hemorrhagic shock in patients from the DGU trauma registry. J Emerg Trauma Shock 2011; 4: 465-71.
37. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38: 298-304.
38. Meng ZH, Wolberg AS, Monroe DM 3rd, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003; 55: 886-91.
39. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma Injury Infect Crit Care 2009; 67: 202-09.
40. Darlington DN, Kheirabadi BS, Delgado AV, Scherer MR, Martini WZ, Dubick MA. Coagulation changes to systemic acidosis and bicarbonate correction in swine. J Trauma Injury Infect Crit Care 2011; 71: 1271-77.
41. Davenport RA, Brohi K. Coagulopathy in trauma patients: importance of thrombocyte function? Curr Opin Anaesthes 2009; 22: 261-66.
42. Wohlauer MV, Moore EE, Thomas S, et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg 2012; 214: 739-46.
43. Cotton BA, McCarthy JJ, Holcomb JB. Acutely injured patients on dabigatran. N Engl J Med 2011; 365: 2039-40.
44. Kautza BC, Cohen MJ, Cuschieri J, et al. Changes in massive transfusion over time: an early shift in the right direction? J Trauma Acute Care Surg 2012; 72: 106-11.
45. Godier A, Samama C-M, Susen S. Plasma/platelets/red blood cell ratio in the management of the bleeding traumatized patient: does it matter? Curr Opin Anesthes 2012; 25: 242-47.
46. Martinaud C, Ausset S, Deshayes AV, Cauet A, Demazeau N, Sailliol A. Use of freeze-dried plasma in french intensive care unit in Afghanistan. J Trauma Injury Infect Crit Care 2011; 71: 1761-64.
47. Spoerke N, Zink K, Cho SD, et al. Lyophilized plasma for resuscitation in a swine model of severe injury. Arch Surg 2009; 144: 829-34.
48. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009; 197: 565-70.
49. Inaba K, Lustenberger T, Rhee P, et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 2010; 211: 573-79.
50. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64 (suppl): S79-80.
51. Ho AM-H, Dion PW, Yeung JHH, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma: erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology 2012; 116: 716-28.
52. Neal MD, Hoffman MK, Cuschieri J, et al. Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: When a little goes a long way. J Trauma Acute Care Surg 2012; 72: 892-98.
53. Armand R, Hess Jr. Treating coagulopathy in trauma patients. Transfus Med Rev 2003; 17: 223-31.
54. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
55. Meyer MAS, Ostrowski SR, Windelov NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang 2011; 101: 185-90.
56. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma Injury Infect Crit Care 2005; 59: 8-18.
57. Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma Injury Infect Crit Care 2010; 69: 489-500.
58. Joseph B, Amini A, Friese RS, et al. Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 2012; 72: 828-34.
59. Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100: 792-97.
60. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
61. Cotton BA, Guy JS, Morris Jr JA, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006; 26: 115-21.
62. Committee on Tactical Combat Casualty Care. Tactical combat casualty care Guidelines. http://www.health.mil/Libraries/110808-TCCC-Course-Materials/TCCC- Guidelines-110808.pdf (accessed July 17, 2012).
63. Development, Concepts and Doctrine Centre. Clinical guidelines for operations: joint doctrine publication 4-03.1. http://www.mod.uk/NR/rdonlyres/ 05E9DB10-E541-4B3C-80BD-A7044FE8F8BB/0/JDP4031CGOsincChg2.pdf (accessed July 17, 2012).
64. Sperry JL, Minei JP, Frankel HL, et al. Early use of vasopressors after injury: caution before constriction. J Trauma 2008; 64: 9-14.
65. Plurad DS, Talving P, Lam L, Inaba K, Green D, Demetriades D. Early vasopressor use in critical injury is associated with mortality independent from volume status. J Trauma Injury Infect Crit Care 2011; 71: 565-72.
66. Doran CM, Doran CA, Woolley T, et al. Targeted resuscitation improves coagulation and outcome. J Trauma Acute Care Surgery 2012; 72: 835-43.
67. Mazzoni MC, Borgstrom P, Arfors KE, Intaglietta M. Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage. Am J Physiol 1988; 255: H629-37.
68. Bulger EM, Cuschieri J, Warner K, Maier RV. Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Ann Surg 2007; 245: 635-41.
69. Bunn F, Roberts I, Tasker R, Akpa E. Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2004; 3: CD002045.
70. Bulger EM, Jurkovich GJ, Nathens AB, et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma. Arch Surg 2008; 143: 139-48.
71. Bulger EM, May S, Kerby JD, et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg 2011; 253: 431-41.
72. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2011; 3: CD001319.
73. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2011; 11: CD001208.
74. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012; 6: CD000567.
75. Wang D, Sun J, Solomon SB, Klein HG, Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2011; published online Dec 21. DOI:10.1111/j.1537-2995.2011.03466.x.
76. Aubron C, Carteaux G, Cooper DJ. Why we must "TRANSFUSE". Crit Care Resus J Australasian Acad Crit Care Med 2011; 13: 67-68.
77. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma Injury Infect Crit Care 2009; 66: S69-76.
78. US Army Institute of Surgical Research Clinical Practice Guidelines. Fresh Whole Blood (FWB) Transfusion. http://www.usaisr.amedd.army.mil/assets/ cpgs/Fresh-Whole-Blood-Transfusion-17-Jul-12.pdf (accessed Aug 29, 2012).
79. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surgery 2002; 236: 814-22.
80. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch Surg 2000; 135: 326-31.
81. Hamilton GJ, Van PY, Differding JA, et al. Lyophilized plasma with ascorbic acid decreases inflammation in hemorrhagic shock. J Trauma Injury Infect Crit Care 2011; 71: 292-98.
82. Van PY, Hamilton GJ, Kremenevskiy IV, et al. Lyophilized plasma reconstituted with ascorbic acid suppresses inflammation and oxidative DNA damage. J Trauma Injury Infect Crit Care 2011; 71: 20-25.
83. Levy JH. Antifibrinolytic therapy: new data and new concepts. Lancet 2010; 376: 3-4.
84. Ipaktchi K, Mattar A, Niederbichler AD, et al. Attenuating burn wound inflammation improves pulmonary function and survival in a burn-pneumonia model. Crit Care Med 2007; 35: 2139-44.
85. Rees K, Beranek-Stanley M, Burke M, Ebrahim S. Hypothermia to reduce neurological damage following coronary artery bypass surgery. Cochrane Database Syst Rev 2001; 1: CD002138.
86. Sydenham E, Roberts I, Alderson P. Hypothermia for traumatic head injury. Cochrane Database Syst Rev 2009; 2; CD001048.
87. Alam HB. Translational barriers and opportunities for emergency preservation and resuscitation in severe injuries. Br J Surg 2012; 99: 29-39.
88. Mitra B, Cameron PA, Gruen RL. Aggressive fresh frozen plasma (FFP) with massive blood transfusion in the absence of acute traumatic coagulopathy. Injury 2012; 43: 33-37.
89. Cotton BA, Dossett LA, Haut ER, et al. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma Injury Infect Crit Care 2010; 69: S33-S38.
90. McLaughlin DF, Niles SE, Salinas J, et al. A predictive model for massive transfusion in combat casualty patients. J Trauma 2008; 64: S57-63.
91. Mitra B, Cameron PA, Mori A, et al. Early prediction of acute traumatic coagulopathy. Resuscitation 2011; 82: 1208-13.
92. Davenport R, Manson J, De'Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-58.
93. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101.
94. Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012; 99: 40-50.